Veterinary Drug Distribution Under Antitrust Pressure: Map Clinic-Supply Dependencies Before a Deal Closes

The U.S. veterinary supply chain has become an antitrust case and an operational warning at the same time. The Federal Trade Commission sued to block Cencora's proposed sale of MWI Animal Health to Covetrus, arguing that combining the country's two largest distributors of veterinary medicines and clinic supplies would eliminate direct competition and increase costs for clinics and pet owners.

The transaction is valued at $3.5 billion. But procurement teams should look beyond the headline price. When two large distributors serve many of the same clinics, manufacturers, distribution territories, and temperature-controlled lanes, a merger review is also a stress test of the physical network. Clinics need to know which apparent alternatives actually depend on the same upstream product, facility, carrier, or allocation policy.

Treat the lawsuit as a dependency signal

Reuters reported that the FTC filed its lawsuit in federal court in New York, while Covetrus said the agency relied on a narrow and outdated market definition. That legal dispute will be decided through evidence about competition. Logistics leaders have a different immediate question: if the network changes, where could service fail before a replacement is ready?

The proposed deal was announced in February 2026 as Cencora narrowed its focus on pharmaceutical distribution. Reuters described the transaction as a sale of MWI to privately held Covetrus at a $3.5 billion valuation. The FTC later characterized the parties as the two largest U.S. distributors in the relevant market. That sequence—deal announcement, regulatory review, then litigation—creates months of uncertainty during which clinics still need uninterrupted supply.

Procurement teams should not wait for a court ruling to discover that their “secondary” source is operationally linked to the primary one. A distributor name is not a complete contingency plan.

Build a dependency map at four levels

Start with products. For every critical medicine, vaccine, diagnostic, surgical item, and clinic consumable, record the manufacturer, item number, approved substitutes, storage range, shelf life, and allocation status. Flag products for which two distributors buy from the same sole manufacturer. A second distributor does not create supply redundancy when both receive the same constrained production output.

Next, map fulfillment facilities. Connect each clinic and product to the normal distribution center, backup DC, cutoff time, replenishment lead time, and inventory owner. Ask whether the nominal backup is a separate building with independent stock or merely another order channel drawing from a shared pool. Include cross-dock points and third-party cold-storage sites that may not appear on an invoice.

Third, map transportation. Capture parcel, LTL, courier, and temperature-controlled carrier assignments by origin-destination pair. Two suppliers can still share the same air gateway, regional carrier, or final-mile depot. That common lane becomes the real single point of failure during weather disruption, capacity rationing, or a network separation ordered as part of a regulatory remedy.

Finally, map commercial and system dependencies. Record contract expiration, minimum order, rebate tier, formulary restriction, electronic catalog, ordering integration, and payment terms. A substitute is not operationally available if it has not been approved by the medical team, loaded into the purchasing system, priced, and tested through receiving.

Distinguish a substitute from a usable substitute

Veterinary distribution has a large customer footprint. Historical Reuters reporting noted that Covetrus, after its formation, represented about 100,000 veterinary practices globally. Scale can improve availability, but it also makes dependency analysis more important: a policy or systems change can affect many sites at once.

Assign every critical line one of four statuses:

• Ready: approved equivalent, active vendor account, validated lane, and sufficient lead time.
• Conditional: substitute exists but requires clinical approval, a contract change, or different storage.
• Constrained: alternate source depends on the same manufacturer, DC region, or carrier capacity.
• None: no qualified replacement within the clinic's maximum interruption window.

The classification should be supported by evidence, not salesperson assurance. Test a small order from each backup path. Confirm lot and expiration capture, temperature evidence, advance shipment notice quality, returns handling, and invoice matching. The test often exposes hidden dependencies that a supplier master cannot show.

Set triggers before service degrades

A contingency plan needs measurable activation points. Monitor fill rate, backorder age, on-time delivery, cold-chain excursions, order cancellations, substitute frequency, and price variance by distributor, product, and clinic. Establish thresholds appropriate to clinical criticality.

For example, a clinic network might move a critical item to controlled allocation when fill rate falls below 95% for two replenishment cycles, release a tested secondary source when a backorder exceeds 48 hours, or reposition inventory when a primary DC misses two consecutive dispatch cutoffs. A sudden routing change, removal of a catalog item, or notice that a facility will separate from the network should create an exception automatically.

Do not use one trigger for every product. Routine consumables can tolerate a longer response window than vaccines, anesthesia products, emergency medicines, or temperature-sensitive biologics. The dependency record should connect each item to its maximum tolerable outage and the person authorized to approve substitution.

Preserve the decision trail

Whether the transaction closes, changes, or is blocked, procurement decisions made during the review need to remain auditable. Store the original order, allocation notice, available substitutes, inventory position, carrier status, approval, and reason for rerouting together. That record helps operations explain higher freight cost, emergency purchasing, or a temporary formulary change later.

CXTMS gives logistics teams a common workflow for product, facility, carrier, and exception data. Teams can identify shared dependencies, apply service triggers, route approved alternatives, and preserve why each shipment decision was made—before consolidation uncertainty becomes a clinic-level shortage.

Request a CXTMS demo to build dependency-aware controls into your healthcare logistics network.